DEL DUCA, Ester
 Distribuzione geografica
Continente #
NA - Nord America 410
AS - Asia 215
EU - Europa 164
AF - Africa 5
SA - Sud America 3
OC - Oceania 1
Totale 798
Nazione #
US - Stati Uniti d'America 402
SG - Singapore 180
IT - Italia 79
RU - Federazione Russa 20
ID - Indonesia 15
SE - Svezia 13
IE - Irlanda 10
IN - India 10
DE - Germania 7
FI - Finlandia 7
GB - Regno Unito 7
CN - Cina 5
BG - Bulgaria 4
CA - Canada 4
MX - Messico 4
BE - Belgio 3
HK - Hong Kong 3
NL - Olanda 3
AT - Austria 2
BR - Brasile 2
HR - Croazia 2
PH - Filippine 2
TG - Togo 2
ZA - Sudafrica 2
AR - Argentina 1
AU - Australia 1
CI - Costa d'Avorio 1
FR - Francia 1
IM - Isola di Man 1
MD - Moldavia 1
NO - Norvegia 1
PL - Polonia 1
RO - Romania 1
UA - Ucraina 1
Totale 798
Città #
Santa Clara 135
Singapore 125
Fairfield 31
Rome 27
Boardman 25
Chandler 23
Ashburn 20
Jakarta 15
Woodbridge 13
Seattle 12
Houston 11
Dublin 10
Milan 10
Moscow 10
Wilmington 7
Cambridge 6
Ann Arbor 5
Helsinki 5
San Diego 5
San Paolo di Civitate 5
Beijing 4
Lawrence 4
London 4
Princeton 4
Sofia 4
Brussels 3
Hong Kong 3
New York 3
Boston 2
Bremen 2
Fiumicino 2
Lomé 2
Millbury 2
Mumbai 2
Munich 2
Naples 2
Nuremberg 2
Ottawa 2
Padova 2
Perugia 2
Plano 2
San Donato Milanese 2
Santa Maria 2
Stilbaai-Wes 2
Toronto 2
Vicopisano 2
West Jordan 2
Zagreb 2
Abidjan 1
Americana 1
Amsterdam 1
Andover 1
Bari 1
Bhopal 1
Carugate 1
Castelforte 1
Chehalis 1
Coimbatore 1
Council Bluffs 1
Des Moines 1
Douglas 1
Federal 1
Florence 1
Fort Worth 1
Frankfurt am Main 1
Gdansk 1
Hackney 1
Las Vegas 1
Los Angeles 1
Messina 1
Oslo 1
Prescot 1
Romola 1
Springfield 1
Sydney 1
São Paulo 1
Verona 1
Vienna 1
Totale 599
Nome #
Cutaneous manifestations in antiphospholipid syndrome 104
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity 91
Psa-disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients. An italian derma-rheuma multicentre study 61
Lymphomatoid drug reaction developed after BNT162b2 (Comirnaty) COVID-19 vaccine manifesting as pityriasis lichenoides et varioliformis acuta-like eruption 46
Blue light-emitting diodes in hair regrowth. the first prospective study 19
Atopic dermatitis and ulcerative colitis successfully treated with upadacitinib 19
Ablative fractional laser improves treatment of actinic keratoses with ingenol mebutate 16
Q-switched 1064/532 nm laser with nanosecond pulse in tattoo treatment. a double-center retrospective study 16
Long-term follow-up for q-switched nd:yag treatment of nevus of ota. are high number of treatments really required? a case report 16
Skin tape-strips in old order mennonite toddlers reveal upregulated barrier markers and low T-helper inflammatory tone 15
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 14
308 nm UV excimer light in monotherapy or combined to topical khellin 4% and/or tacrolimus 0.1% in the treatment of vitiligo 14
Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis. results from an italian multicenter study 14
Nanosecond Q-switched 1064/532 nm laser to treat hyperpigmentations. a double center retrospective study 13
Atopic dermatitis stratification. current and future perspective on skin and blood transcriptomic and proteomic profiling 13
Nd:YAG laser in association with pulsed dye laser for the treatment of PHACES syndrome 13
Association between psoriasis and periodontitis, and efficacy of anti-TNF-α therapy 13
A new 675-nm laser device in the treatment of acne scars. an observational study 12
A case of pincer nail successfully treated with tazarotene 0.1% gel 12
Proteomic analysis from skin swabs reveals a new set of proteins identifying skin impairment in Atopic Dermatitis 11
Autologous platelet-rich fibrin injections in the management of facial cutaneous sinus tracts secondary to medication-related osteonecrosis of the jaw 11
An integrated scalp and blood biomarker approach suggests the systemic nature of alopecia areata 11
Histological skin changes after treatment with 675 nm laser 11
Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis. mechanistic considerations 10
The evolving landscape of biologic therapies for atopic dermatitis. present and future perspective 10
Arsenic and chromium levels in hair correlate with actinic keratosis/non melanoma skin cancer. results of an observational controlled study 10
Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate and 3.75% imiquimod in the treatment of actinic keratosis 10
Rapid, persistent, and simultaneous remission of urticaria and severe atopic dermatitis after treatment with omalizumab 10
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis 10
A phase 2a randomized vehicle-controlled multi-center study of the safety and efficacy of delgocitinib in subjects with moderate-to-severe alopecia areata 10
Daylight photodynamic therapy with 5-aminolevulinic acid 5% gel for the treatment of mild-to-moderate inflammatory acne 10
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis 9
Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways 9
Baseline neutrophil/lymphocyte ratio (NLR) and red blood cell distribution width (RDW) correlate with advanced stages in cutaneous squamous cell carcinoma 9
Transcriptomic profiling of tape-strips from moderate to severe atopic dermatitis patients treated with dupilumab 9
Safety evaluation of apremilast for the treatment of psoriasis 9
Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis 9
Nonconventional use of flash-lamp pulsed-dye laser in dermatology 9
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body. pilot study in skin types IV–VI 9
Combination of apremilast and narrowband ultraviolet B light in the treatment of generalized vitiligo in skin phototypes IV to VI. a randomized split-body pilot study 9
Age of onset defines two distinct profiles of atopic dermatitis in adults 9
Management of laser treatments during the coronavirus disease 2019 pandemic. the italian experience 8
Proteomic signatures of inflammatory skin diseases. a focus on atopic dermatitis 8
UVA1 laser in the treatment of vitiligo 8
Diversity of atopic dermatitis and selection of immune targets 8
Transcriptomic evaluation of skin tape-strips in children with allergic asthma uncovers epidermal barrier dysfunction and asthma-associated biomarkers abnormalities 8
Treat-to-target in dermatology. a scoping review and international eczema council survey on the approach in atopic dermatitis 8
IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases 8
Hyperactivation of the JAK2/STAT5 signaling pathway and evaluation of baricitinib treatment among patients with eosinophilic cellulitis 8
The translational revolution in atopic dermatitis. the paradigm shift from pathogenesis to treatment 8
RNA sequencing keloid transcriptome associates keloids with Th2, Th1, Th17/Th22, and JAK3-skewing 8
Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers 7
Cutaneous body image in psoriasis. the role of attachment style and alexithymia 7
Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis 7
Major differences in expression of inflammatory pathways in skin from different body sites of healthy individuals 7
Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin 7
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases 7
TFOS lifestyle. Impact of cosmetics on the ocular surface 7
Intrapatient comparison of atopic dermatitis skin transcriptome shows differences between tape-strips and biopsies 7
Long-pulsed 1064-nm Nd:YAG laser for the treatment of onychomycosis 7
Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis 7
Etanercept biosimilar SB4 in the treatment of plaque-type psoriasis and psoriatic arthritis. a single-centre, observational, retrospective, real-life study 7
Alopecia areata. current treatments and new directions 7
Cytokine pathways and investigational target therapies in hidradenitis suppurativa 7
Telomere and telomerase modulation by bergamot polyphenolic fraction in experimental photoageing in human keratinocytes 7
Proteomic characterization of atopic dermatitis blood from infancy to adulthood 7
Drugs for the treatment of chronic hand eczema. successes and key challenges 7
Proteomic alterations in patients with atopic dermatitis 7
Long-pulsed 755-nm alexandrite laser equipped with a sapphire handpiece. unwanted hair removal in darker phototypes 7
Fractional CO2 laser. from skin rejuvenation to vulvo-vaginal reshaping 7
Reducing the oral isotretinoin skin side effects. efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients 7
Immune and barrier characterization of atopic dermatitis skin phenotype in tanzanian patients 7
Scalp biomarkers during dupilumab treatment support Th2 pathway pathogenicity in alopecia areata 7
SARS-CoV-2 receptor ACE2 protein expression in serum is significantly associated with age 7
Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis 6
The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults 6
Efficacy of vismodegib in pigmented basal cell carcinoma. appearances are deceiving 6
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. a two-center. prospective assessor-blinded, proof-of-concept study 6
Depressive symptoms and insecure attachment predict disability and quality of life in psoriasis independently from disease severity 6
Frontal fibrosing alopecia shows robust T helper 1 and janus kinase 3 skewing 6
Pharmacoeconomy of drugs used in the treatment of actinic keratoses 6
Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement 6
Combined CO2 and dye laser technique in the treatment of outcomes due to flap necrosis after surgery for basal cell carcinoma on the nose 6
Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin 6
High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitis 6
Repurposing DPP4 inhibition to improve hair follicle activation and regeneration 6
Distinct skin microbiome community structures in congenital ichthyosis 6
Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities 6
Cutaneous mastocytosis. a dermatological perspective 6
Potential applications of topical oxygen therapy in dermatology 6
Transcriptomic analysis of the major orphan ichthyosis subtypes reveals shared immune and barrier signatures 6
Update of calcineurin inhibitors to treat inverse psoriasis. a systematic review 6
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo 6
Tape-strips provide a minimally invasive approach to track therapeutic response to topical corticosteroids in atopic dermatitis patients 6
Totale 1.096
Categoria #
all - tutte 6.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 5 4 4 4 2 6
2020/202137 3 4 0 0 0 0 0 2 10 18 0 0
2021/202249 0 5 2 1 4 2 5 3 3 3 13 8
2022/202379 9 17 7 10 5 8 0 7 10 1 5 0
2023/2024427 1 1 92 10 15 9 3 6 2 21 16 251
2024/2025423 47 45 68 60 131 69 3 0 0 0 0 0
Totale 1.096